CR Rates in Relapsed/Refractory Aggressive B-NHL Treated With the CD19-Directed CAR T-Cell Product JCAR017 (TRANSCEND NHL 001)

[Anonymous]

CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2017; 15 (9): 13

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索